Biomanufacturing is central to a projected $1T U.S. bioeconomy, yet our ability to make biologically enabled products lags our ability to design them. In this talk, I’ll describe how MIT’s Initiative for New Manufacturing (MIT INM) is seeking to transform manufacturing across the nation and some lessons learned so far. I will then focus on how we are rethinking biomanufacturing to expand the industry's infrastructure: smaller, modular, and continuous facilities; standardized, platform processes across product classes; and AI-enabled design and operations.  I’ll highlight why we should think differently to build distributed, resilient capacity that shortens the time from idea to impact, strengthens supply chains, and creates high-quality jobs in the next-generation bioeconomy.

J. Christopher Love is the Raymond A. (1921) and Helen E. St. Laurent Professor of Chemical Engineering at MIT and Associate Director of the Koch Institute for Integrative Cancer Research. He is an associate member of the Broad Institute and the Ragon Institute of MGH, MIT, and Harvard. He co-directs the MIT Initiative for New Manufacturing and the Leaders for Global Operations program and founded MIT’s Alternative Host Research Consortium. Love has co-founded multiple biotechnology companies, including Honeycomb Bio, OneCyte Bio, Sunflower Therapeutics, and Amplifyer Bio.
The Love Lab (MIT)
More info about Dr. Love's 3/4 seminar here